Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Prim. 2021;7(1):47. [Pubmed]
Alcolea D, Clarimón J, Carmona-Iragui M, Illán-Gala I, Morenas-Rodríguez E, Barroeta I, et al. The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders. Alzheimer’s Dement Transl Res Clin Interv. 2019;5. [Pubmed]
Arévalo-Rodríguez I, Smailagic N, Roqué I Figuls M, Ciapponi A, Sánchez-Pérez E, Giannakou A, et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. [Pubmed]
Boccardi M, Monsch AU, Ferrari C, Altomare D, Berres M, Bos I, et al.; Consortium for the Harmonization of Neuropsychological Assessment for Neurocognitive Disorders. Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe. Alzheimers Dement. 2022 Jan;18(1):29-42. [Pubmed]
Carnero-Pardo C, Rego-García I, Mené Llorente M, Alonso Ródenas M, Vílchez Carrillo R. Diagnostic performance of brief cognitive tests in cognitive impairment screening. Neurologia (Engl Ed). 2019 Aug 8:S0213-4853(19)30086-6. [Pubmed]
Coyle-Gilchrist ITS, Dick KM, Patterson K, Vázquez Rodríquez P, Wehmann E, Wilcox A, et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology. 2016 May;86(18):1736-43. [Pubmed]
Custodio N, Lira D, Herrera-Pérez E, Núñez del Prado L, Parodi J, Guevara-Silva E, et al. The Memory Alteration Test Discriminates between Cognitively Healthy Status, Mild Cognitive Impairment and Alzheimer's Disease. Dement Geriatr Cogn Dis Extra. 2014 Aug 27;4(2):314-21. [Pubmed]
Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, et al. Clinical diagnosis of Alzheimer’s disease: recommendations of the International Working Group. Lancet Neurol. 2021 Jun;20(6):484-96. [Pubmed]
Finger EC. Frontotemporal Dementias. Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):464-89. [Pubmed]
Galvin JE. Improving the clinical detection of Lewy body dementia with the Lewy Body Composite Risk Score. Alzheimers Dement (Amst). 2015 Sep 1;1(3):316-24. [Pubmed]
Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, et al. New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol. 2021 Mar;20(3):222-34. [Pubmed]
Jongsiriyanyong S, Limpawattana P. Mild Cognitive Impairment in Clinical Practice: A Review Article. Am J Alzheimers Dis Other Demen. 2018 Dec;33(8):500-7. [Pubmed]
Leroy M, Bertoux M, Skrobala E, Mode E, Adnet-Bonte C, Le Ber I, et al. Characteristics and progression of patients with frontotemporal dementia in a regional memory clinic network. Alzheimers Res Ther. 2021;13(1):19. [Pubmed]
Marshall CR, Hardy CJD, Volkmer A, Russell LL, Bond RL, Fletcher PD, et al. Primary progressive aphasia: a clinical approach. J Neurol. 2018 Jun;265(6):1474-90. [Pubmed]
McCollum L, Karlawish J. Cognitive Impairment Evaluation and Management. Med Clin North Am. 2020 Sep;104(5):807-25. [Pubmed]
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017 Jul;89(1):88-100. [Pubmed]
McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020 Apr 28;94(17):743-55. [Pubmed]
Olney NT, Spina S, Miller BL. Frontotemporal Dementia. Neurol Clin. 2017 May;35(2):339-74. [Pubmed]
Petersen RC. Mild Cognitive Impairment. Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):404-18. [Pubmed]
Rami L, Bosch B, Sánchez-Valle R, Molinuevo JL. The memory alteration test (M@T) discriminates between subjective memory complaints, mild cognitive impairment and Alzheimer’s disease. Arch Gerontol Geriatr. 2010;50(2):171-4. [Pubmed]
Rikkert MGMO, Tona KD, Janssen L, Burns A, Lobo A, Robert P, et al. Validity, reliability, and feasibility of clinical staging scales in dementia: a systematic review. Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):357-65. [Pubmed]
Si T, Xing G, Han Y. Subjective Cognitive Decline and Related Cognitive Deficits. Front Neurol. 2020;11:247. [Pubmed]
Sirkis DW, Bonham LW, Johnson TP, La Joie R, Yokoyama JS. Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease. Mol Psychiatry. 2022 Jun;27(6):2674-88. [Pubmed]
Tainta M, Iriondo A, Ecay-Torres M, Estanga A, de Arriba M, Barandiaran M, et al. Brief cognitive tests as a decision-making tool in primary care. A population and validation study. Neurologia (Engl Ed). 2022 Aug 10:S2173-5808(22)00082-7. [Pubmed]
Tzeng RC, Yang YW, Hsu KC, Chang HT, Chiu PY. Sum of boxes of the clinical dementia rating scale highly predicts conversion or reversion in predementia stages. Front Aging Neurosci. 2022;14:1021792. [Pubmed]
Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K, et al. Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions. J Mov Disord. 2020 Jan;13(1):1-10. [Pubmed]
Zhang Q, Aldridge GM, Narayanan NS, Anderson SW, Uc EY. Approach to Cognitive Impairment in Parkinson’s Disease. Neurotherapeutics. 2020;17(4):1495-510. [Pubmed]